Bausch Health Companies (BHC) Competitors

C$7.70 +0.19 (+2.53%)

As of 04:00 PM Eastern

BHC vs. APHA, PBH, SLS, AUP, and CARA

Should you be buying Bausch Health Companies stock or one of its competitors? The main competitors of Bausch Health Companies include Aphria (APHA), Premium Brands (PBH), Solaris Resources (SLS), Aurinia Pharmaceuticals (AUP), and Cara Operations (CARA). These companies are all part of the "pharmaceutical products" industry.

How does Bausch Health Companies compare to Aphria?

Aphria (TSE:APHA) and Bausch Health Companies (TSE:BHC) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

: In the previous week, Bausch Health Companies had 4 more articles in the media than Aphria. MarketBeat recorded 4 mentions for Bausch Health Companies and 0 mentions for Aphria. Bausch Health Companies' average media sentiment score of 0.22 beat Aphria's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media.
Company Overall Sentiment
Aphria Neutral
Bausch Health Companies Neutral
: Bausch Health Companies has higher revenue and earnings than Aphria. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aphria C$611.06M 0.00 -C$637.39M -C$2.01 N/A
Bausch Health Companies C$10.53B 0.27 -C$125.65M -C$3.24 N/A
: 13.5% of Bausch Health Companies shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: Aphria has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Aphria's return on equity.
Company Net Margins Return on Equity Return on Assets
Aphria N/A N/A N/A
Bausch Health Companies -13.54% 120.43% 4.16%
: Given Aphria's higher probable upside, analysts clearly believe Aphria is more favorable than Bausch Health Companies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aphria
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Bausch Health Companies
0 Sell rating(s)

2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00

Company	Overall Sentiment
Aphria	Neutral
Bausch Health Companies	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aphria	C$611.06M	0.00	-C$637.39M	-C$2.01	N/A
Bausch Health Companies	C$10.53B	0.27	-C$125.65M	-C$3.24	N/A

Company	Net Margins	Return on Equity	Return on Assets
Aphria	N/A	N/A	N/A
Bausch Health Companies	-13.54%	120.43%	4.16%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aphria	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Bausch Health Companies beats Aphria on 10 of the 13 factors compared between the two stocks.

How does Bausch Health Companies compare to Premium Brands?

Premium Brands (TSE:PBH) and Bausch Health Companies (TSE:BHC) are both mid-cap pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

: Premium Brands has a net margin of 0.54% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Premium Brands' return on equity.
Company Net Margins Return on Equity Return on Assets
Premium Brands 0.54% 2.38% 3.61%
Bausch Health Companies -13.54% 120.43% 4.16%
: Premium Brands has a beta of 0.860077, meaning that its stock price is 14% less volatile than the S&P 500. Comparatively, Bausch Health Companies has a beta of 0.588188, meaning that its stock price is 41% less volatile than the S&P 500.
: In the previous week, Premium Brands had 2 more articles in the media than Bausch Health Companies. MarketBeat recorded 6 mentions for Premium Brands and 4 mentions for Bausch Health Companies. Premium Brands' average media sentiment score of 0.39 beat Bausch Health Companies' score of 0.22 indicating that Premium Brands is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Premium Brands
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bausch Health Companies
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 33.0% of Premium Brands shares are held by institutional investors. Comparatively, 13.5% of Bausch Health Companies shares are held by institutional investors. 2.0% of Premium Brands shares are held by company insiders. Comparatively, 11.3% of Bausch Health Companies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
: Premium Brands currently has a consensus price target of C$116.36, indicating a potential upside of 40.35%. Given Premium Brands' stronger consensus rating and higher possible upside, research analysts clearly believe Premium Brands is more favorable than Bausch Health Companies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Premium Brands
0 Sell rating(s)
1 Hold rating(s)

7 Buy rating(s)

1 Strong Buy rating(s)
3.00
Bausch Health Companies
0 Sell rating(s)

2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Premium Brands has higher earnings, but lower revenue than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Premium Brands, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Premium Brands C$7.48B 0.58 C$99.56M C$0.90 92.12
Bausch Health Companies C$10.53B 0.27 -C$125.65M -C$3.24 N/A

Company	Net Margins	Return on Equity	Return on Assets
Premium Brands	0.54%	2.38%	3.61%
Bausch Health Companies	-13.54%	120.43%	4.16%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Premium Brands	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bausch Health Companies	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Premium Brands	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Premium Brands	C$7.48B	0.58	C$99.56M	C$0.90	92.12
Bausch Health Companies	C$10.53B	0.27	-C$125.65M	-C$3.24	N/A

Summary

Premium Brands beats Bausch Health Companies on 13 of the 17 factors compared between the two stocks.

How does Bausch Health Companies compare to Solaris Resources?

Bausch Health Companies (TSE:BHC) and Solaris Resources (TSE:SLS) are both mid-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

: Solaris Resources has lower revenue, but higher earnings than Bausch Health Companies. Solaris Resources is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bausch Health Companies C$10.53B 0.27 -C$125.65M -C$3.24 N/A
Solaris Resources N/A N/A -C$46.49M -C$0.26 N/A
: Solaris Resources has a consensus target price of C$19.50, indicating a potential upside of 47.17%. Given Solaris Resources' stronger consensus rating and higher possible upside, analysts plainly believe Solaris Resources is more favorable than Bausch Health Companies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
Solaris Resources
0 Sell rating(s)

0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
: Bausch Health Companies has a beta of 0.588188, suggesting that its stock price is 41% less volatile than the S&P 500. Comparatively, Solaris Resources has a beta of 1.845161, suggesting that its stock price is 85% more volatile than the S&P 500.
: 13.5% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 16.1% of Solaris Resources shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by insiders. Comparatively, 40.6% of Solaris Resources shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
: Solaris Resources has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Solaris Resources' return on equity.
Company Net Margins Return on Equity Return on Assets
Bausch Health Companies -13.54% 120.43% 4.16%
Solaris Resources N/A 96.23% -51.67%
: In the previous week, Bausch Health Companies had 3 more articles in the media than Solaris Resources. MarketBeat recorded 4 mentions for Bausch Health Companies and 1 mentions for Solaris Resources. Solaris Resources' average media sentiment score of 0.48 beat Bausch Health Companies' score of 0.22 indicating that Solaris Resources is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch Health Companies
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Solaris Resources
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.27	-C$125.65M	-C$3.24	N/A
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.26	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Solaris Resources	N/A	96.23%	-51.67%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch Health Companies	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Solaris Resources	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Solaris Resources beats Bausch Health Companies on 10 of the 15 factors compared between the two stocks.

How does Bausch Health Companies compare to Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals (TSE:AUP) and Bausch Health Companies (TSE:BHC) are both mid-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

: Given Aurinia Pharmaceuticals' higher possible upside, equities analysts plainly believe Aurinia Pharmaceuticals is more favorable than Bausch Health Companies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurinia Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Bausch Health Companies
0 Sell rating(s)

2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Bausch Health Companies has higher revenue and earnings than Aurinia Pharmaceuticals. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aurinia Pharmaceuticals C$57.59M 0.00 -C$190.03M -C$1.48 N/A
Bausch Health Companies C$10.53B 0.27 -C$125.65M -C$3.24 N/A
: 13.5% of Bausch Health Companies shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
: Aurinia Pharmaceuticals has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Aurinia Pharmaceuticals' return on equity.
Company Net Margins Return on Equity Return on Assets
Aurinia Pharmaceuticals N/A N/A N/A
Bausch Health Companies -13.54% 120.43% 4.16%
: In the previous week, Bausch Health Companies had 4 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 4 mentions for Bausch Health Companies and 0 mentions for Aurinia Pharmaceuticals. Bausch Health Companies' average media sentiment score of 0.22 beat Aurinia Pharmaceuticals' score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media.
Company Overall Sentiment
Aurinia Pharmaceuticals Neutral
Bausch Health Companies Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A
Bausch Health Companies	C$10.53B	0.27	-C$125.65M	-C$3.24	N/A

Company	Net Margins	Return on Equity	Return on Assets
Aurinia Pharmaceuticals	N/A	N/A	N/A
Bausch Health Companies	-13.54%	120.43%	4.16%

Company	Overall Sentiment
Aurinia Pharmaceuticals	Neutral
Bausch Health Companies	Neutral

Summary

Bausch Health Companies beats Aurinia Pharmaceuticals on 10 of the 13 factors compared between the two stocks.

How does Bausch Health Companies compare to Cara Operations?

Cara Operations (TSE:CARA) and Bausch Health Companies (TSE:BHC) are both pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

: 13.5% of Bausch Health Companies shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
: Given Cara Operations' higher probable upside, equities research analysts clearly believe Cara Operations is more favorable than Bausch Health Companies.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cara Operations
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Bausch Health Companies
0 Sell rating(s)

2 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
2.00
: Cara Operations has a net margin of 0.00% compared to Bausch Health Companies' net margin of -13.54%. Bausch Health Companies' return on equity of 120.43% beat Cara Operations' return on equity.
Company Net Margins Return on Equity Return on Assets
Cara Operations N/A N/A N/A
Bausch Health Companies -13.54% 120.43% 4.16%
: In the previous week, Bausch Health Companies had 4 more articles in the media than Cara Operations. MarketBeat recorded 4 mentions for Bausch Health Companies and 0 mentions for Cara Operations. Bausch Health Companies' average media sentiment score of 0.22 beat Cara Operations' score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media.
Company Overall Sentiment
Cara Operations Neutral
Bausch Health Companies Neutral
: Cara Operations has higher earnings, but lower revenue than Bausch Health Companies.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cara Operations N/A N/A N/A N/A N/A
Bausch Health Companies C$10.53B 0.27 -C$125.65M -C$3.24 N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Company	Net Margins	Return on Equity	Return on Assets
Cara Operations	N/A	N/A	N/A
Bausch Health Companies	-13.54%	120.43%	4.16%

Company	Overall Sentiment
Cara Operations	Neutral
Bausch Health Companies	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cara Operations	N/A	N/A	N/A	N/A	N/A
Bausch Health Companies	C$10.53B	0.27	-C$125.65M	-C$3.24	N/A

Summary

Bausch Health Companies beats Cara Operations on 8 of the 10 factors compared between the two stocks.

Get Bausch Health Companies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BHC vs. The Competition

Export

Metric	Bausch Health Companies	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$2.88B	C$1.63B	C$6.25B	C$11.72B
Dividend Yield	0.76%	2.97%	2.73%	6.22%
P/E Ratio	-2.38	4.18	29.04	23.83
Price / Sales	0.27	1,488.53	476.61	13.46
Price / Cash	7.76	10.37	27.62	82.69
Price / Book	-2.64	10.72	9.67	4.48
Net Income	-C$125.65M	C$21.15B	C$3.55B	C$300.68M
7 Day Performance	-0.90%	-1.18%	1.70%	0.12%
1 Month Performance	2.94%	0.15%	5.62%	2.88%
1 Year Performance	12.90%	24.15%	34.42%	57.78%

Bausch Health Companies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BHC Bausch Health Companies	0.5813 of 5 stars	C$7.70 +2.5%	N/A	N/A	C$2.88B	C$10.53B	N/A	19,900	Earnings Report
APHA Aphria	N/A	N/A	N/A	N/A	C$5.24B	C$611.06M	N/A	1,200
PBH Premium Brands	3.434 of 5 stars	C$83.63 +0.5%	C$116.36 +39.1%	N/A	C$4.35B	C$7.48B	92.92	540
SLS Solaris Resources	1.6716 of 5 stars	C$13.58 -1.9%	C$19.50 +43.6%	N/A	C$2.27B	N/A	N/A	10
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:BHC) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bausch Health Companies (BHC) Competitors

BHC vs. APHA, PBH, SLS, AUP, and CARA

How does Bausch Health Companies compare to Aphria?

Summary

How does Bausch Health Companies compare to Premium Brands?

Summary

How does Bausch Health Companies compare to Solaris Resources?

Summary

How does Bausch Health Companies compare to Aurinia Pharmaceuticals?

Summary

How does Bausch Health Companies compare to Cara Operations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHC vs. The Competition

Bausch Health Companies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bausch Health Companies (BHC) Competitors

BHC vs. APHA, PBH, SLS, AUP, and CARA

How does Bausch Health Companies compare to Aphria?

Summary

How does Bausch Health Companies compare to Premium Brands?

Summary

How does Bausch Health Companies compare to Solaris Resources?

Summary

How does Bausch Health Companies compare to Aurinia Pharmaceuticals?

Summary

How does Bausch Health Companies compare to Cara Operations?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BHC vs. The Competition

Bausch Health Companies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools